Machine Learning

Pharma giant Bayer partners with AI innovator Cradle, betting on generative AI to accelerate its biologics pipeline and reshape modern medicine.

With positive Phase 2 results for its antibody AP-101, AL-S Pharma targets a key protein in both genetic and sporadic forms of ALS, offering new hope.

New data from a major Swedish study reveals SAGA Diagnostics' Pathlight test can predict colorectal cancer recurrence with remarkable accuracy, changing the game.

A new blood test in Western Canada promises to detect 59 cancers early. But with a high price tag and pending approval, it raises critical questions.

The MTA's major investment in Wabtec's hybrid locomotives promises cleaner air for New York, safer work for crews, and a more reliable subway system.

LUMA Vision's VERAFEYE™ system combines AI with real-time 4D heart visualization, promising to make complex AFib procedures faster, safer, and more precise.

Following record financial growth, RadNet promotes four executives to accelerate its shift toward proactive, AI-driven healthcare and expand its market dominance.

A new multi-target deal combines cutting-edge platforms to create next-gen cancer drugs, aiming to improve precision and patient outcomes.

A new alliance pairs Relation's 'Lab-in-the-Loop' AI with Deerfield's investment might, aiming to fast-track novel drugs for intractable diseases.

With seasoned executive Adam Rosenberg at the helm, AstronauTx is advancing its novel sleep-focused therapy, backed by major investors, into the Alzheimer's arena.

At CES 2026, a powerful innovation engine called XbotPark & InnoX is showcasing over 40 AI hardware startups, revealing a new model for building tech giants.

Startup Guangfan Technology debuts vision-enabled AI earbuds at CES, promising a proactive assistant that sees your world. But is society ready for it?

A first-in-class antibody shows a strong safety profile, de-risking development and offering a new, targeted approach for severe autoimmune diseases.

NVIDIA CEO Jensen Huang wins the 2026 IEEE Medal of Honor, a nod to his visionary work that sparked an AI revolution and a $5 trillion empire.

A new $65 million facility for a top U.S. intelligence lab cements Maryland's role as a national security research powerhouse. Here's what it means.

LifeVantage heads to the ICR Conference to woo investors. Can its cellular health science overcome market headwinds and a volatile direct selling landscape?

Chemelex's buyout of EHT Group integrates the SmartTrace platform, signaling a major shift toward AI-driven predictive maintenance in industrial heat tracing.

A landmark trial reveals a new drug combination from BeOne Medicines extends life significantly in advanced stomach cancer, poised to become the new standard.

Linkind unveils AI-powered lighting at CES 2026, from solar lights with app-controlled patterns to a system that creates light shows from speech.

The first-ever Wegovy pill is here. Digital health firm eMed is partnering with Novo Nordisk to offer it, promising a new era of guided, responsible care.